Hepatic conditioning results in better lung endothelial cell preservation under hypoxic environment in vitro
Kentaro Noda,
No information about this author
Neha Atale,
No information about this author
Taylor J. Austin
No information about this author
et al.
The International Journal of Artificial Organs,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 30, 2025
Background:
as
we
look
to
extend
ex
vivo
lung
perfusion
times
(EVLP)
improve
preservation,
the
metabolic
activity
of
lungs
will
require
support
from
other
organ
functions.
Active
functional
liver
support,
including
detoxification,
synthesis,
and
regulation,
can
preservation
during
EVLP.
This
study
aimed
demonstrate
effects
hepatic
conditioning
EVLP
perfusate
on
endothelium,
via
receptor
advanced
glycation
end-products
(RAGE)-nuclear-factor-κB
(NF-κB)
signaling
in
vitro.
Methods:
performed
vitro
experiments
using
human
microvascular
endothelial
cells
(HLMVECs),
hepatocytes,
(Steen
solution).
Four
experimental
groups:
1)
fresh
Steen
(negative
controls,
NC),
2)
EVLP’ed
control,
this
solution
collected
after
12
h
lungs,
3)
hepatocyte
conditioned
(Hep-cond.),
4)
a
RAGE
inhibitor
added
(RAGE
inhibitor).
HLMVECs
were
incubated
each
testing
condition
exposed
hypoxia
(1%
O
2
/8%
CO
)
for
24
h.
Media
investigate
NF-κB
glycocalyx
damage.
Results:
under
showed
significantly
upregulated
signal
damage
denoted
by
increased
glycosaminoglycans
matrix
metalloproteinase-2
among
groups.
The
Hep-cond.
attenuated
those
findings,
while
but
not
Conclusion:
Our
demonstrates
that
function
incorporated
into
ameliorate
pulmonary
injury
hypoxic
normothermic
exposure.
data
supports
concept
incorporating
functions
an
platform,
enhance
graft
preservation.
Language: Английский
Identification and validation of biomarkers related to mitochondria during ex vivo lung perfusion for lung transplants based on machine learning algorithm
Zhi-Chang Yang,
No information about this author
Weihua Lu,
No information about this author
Zhen-Yang Geng
No information about this author
et al.
Gene,
Journal Year:
2024,
Volume and Issue:
936, P. 149097 - 149097
Published: Nov. 15, 2024
Ex
vivo
lung
perfusion
(EVLP)
is
a
critical
strategy
to
rehabilitate
marginal
donor
lungs,
thereby
increasing
transplantation
(LTx)
rates.
Ischemia-reperfusion
(I/R)
injury
inevitably
occurs
during
LTx.
Exploring
the
common
mechanisms
between
EVLP
and
I/R
may
unveil
new
treatment
targets
enhance
LTx
outcomes.
Language: Английский